Baxter EBIT 2010-2024 | BAX

Baxter annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Baxter EBIT for the quarter ending September 30, 2024 was $0.155B, a 13.41% decline year-over-year.
  • Baxter EBIT for the twelve months ending September 30, 2024 was $249M, a 50.3% decline year-over-year.
  • Baxter 2023 annual EBIT was $0.39B, a 117.39% decline from 2022.
  • Baxter 2022 annual EBIT was $-2.243B, a 266.15% decline from 2021.
  • Baxter 2021 annual EBIT was $1.35B, a 16.46% decline from 2020.
Baxter Annual EBIT
(Millions of US $)
2023 $390
2022 $-2,243
2021 $1,350
2020 $1,616
2019 $1,772
2018 $1,584
2017 $1,288
2016 $745
2015 $449
2014 $656
2013 $496
2012 $2,770
2011 $2,946
2010 $2,136
2009 $2,877
Baxter Quarterly EBIT
(Millions of US $)
2024-09-30 $155
2024-06-30 $-192
2024-03-31 $187
2023-12-31 $99
2023-09-30 $179
2023-06-30 $-17
2023-03-31 $129
2022-12-31 $210
2022-09-30 $-2,880
2022-06-30 $264
2022-03-31 $163
2021-12-31 $23
2021-09-30 $513
2021-06-30 $424
2021-03-31 $390
2020-12-31 $406
2020-09-30 $470
2020-06-30 $331
2020-03-31 $409
2019-12-31 $536
2019-09-30 $503
2019-06-30 $350
2019-03-31 $383
2018-12-31 $386
2018-09-30 $382
2018-06-30 $384
2018-03-31 $432
2017-12-31 $288
2017-09-30 $300
2017-06-30 $347
2017-03-31 $353
2016-12-31 $303
2016-09-30 $186
2016-06-30 $68
2016-03-31 $188
2015-12-31 $178
2015-09-30 $92
2015-06-30 $87
2015-03-31 $92
2014-12-31 $191
2014-09-30 $217
2014-06-30 $659
2014-03-31 $672
2013-12-31 $546
2013-09-30 $654
2013-06-30 $828
2013-03-31 $715
2012-12-31 $523
2012-09-30 $777
2012-06-30 $777
2012-03-31 $693
2011-12-31 $625
2011-09-30 $745
2011-06-30 $831
2011-03-31 $745
2010-12-31 $523
2010-09-30 $782
2010-06-30 $698
2010-03-31 $133
2009-12-31 $733
2009-09-30 $732
2009-06-30 $747
2009-03-31 $665
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.940B $14.813B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $196.757B 25.10
Stryker (SYK) United States $136.750B 30.82
Boston Scientific (BSX) United States $131.731B 37.87
EssilorLuxottica (ESLOY) France $109.710B 0.00
Medtronic (MDT) Ireland $102.865B 15.28
Haleon (HLN) United Kingdom $42.732B 27.76
Lonza Group Ag (LZAGY) Switzerland $42.382B 0.00
GE HealthCare Technologies (GEHC) United States $35.810B 18.57
ResMed (RMD) United States $33.540B 27.56
Terumo (TRUMY) Japan $28.681B 40.51
Koninklijke Philips (PHG) Netherlands $23.480B 17.97
Zimmer Biomet Holdings (ZBH) United States $20.795B 13.24
Insulet (PODD) United States $18.017B 71.75
Smith & Nephew SNATS (SNN) United Kingdom $10.667B 0.00
BellRing Brands (BRBR) United States $9.606B 38.65
Bio-Rad Laboratories (BIO) United States $9.131B 31.03
Demant (WILYY) Denmark $8.251B 0.00
Lantheus Holdings (LNTH) United States $6.174B 14.35
Haemonetics (HAE) United States $3.938B 19.22
ICU Medical (ICUI) United States $3.868B 36.83
Prestige Consumer Healthcare (PBH) United States $3.840B 19.10
Perrigo (PRGO) Ireland $3.547B 10.44
Envista Holdings (NVST) United States $3.289B 24.50
QuidelOrtho (QDEL) United States $3.029B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.863B 18.36
Neogen (NEOG) United States $2.587B 29.85
LeMaitre Vascular (LMAT) United States $2.057B 49.98
Green Thumb Industries (GTBIF) United States $1.724B 30.17
AtriCure (ATRC) United States $1.482B 0.00
InMode (INMD) Israel $1.424B 8.57
Maravai LifeSciences Holdings (MRVI) United States $1.386B 0.00
AdaptHealth (AHCO) United States $1.305B 9.33
BioLife Solutions (BLFS) United States $1.214B 0.00
Curaleaf Holdings (CURLF) Canada $1.066B 0.00
Owens & Minor (OMI) United States $0.991B 7.74
CeriBell (CBLL) United States $0.926B 0.00
Phibro Animal Health (PAHC) United States $0.840B 14.81
Evolus (EOLS) United States $0.704B 0.00
Capricor Therapeutics (CAPR) United States $0.680B 0.00
VAREX IMAGING (VREX) United States $0.594B 26.20
Omeros (OMER) United States $0.570B 0.00
Surmodics (SRDX) United States $0.567B 0.00
Verano Holdings (VRNOF) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.463B 0.00
Quanterix (QTRX) United States $0.415B 0.00
Valneva SE (VALN) France $0.384B 0.00
ZimVie (ZIMV) United States $0.382B 32.16
Biote (BTMD) United States $0.328B 7.18
Viemed Healthcare (VMD) United States $0.317B 30.11
Canopy Growth (CGC) Canada $0.314B 0.00
Cerus (CERS) United States $0.292B 0.00
Sanara MedTech (SMTI) United States $0.289B 0.00
High Tide (HITI) Canada $0.269B 110.67
OraSure Technologies (OSUR) United States $0.264B 17.70
Zynex (ZYXI) United States $0.249B 52.07
Aurora Cannabis (ACB) Canada $0.247B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.208B 14.37
MacroGenics (MGNX) United States $0.207B 0.00
TerrAscend (TSNDF) Canada $0.205B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.180B 95.80
TriSalus Life Sciences (TLSI) United States $0.152B 0.00
Jin Medical (ZJYL) China $0.149B 0.00
FitLife Brands (FTLF) United States $0.148B 18.59
Quipt Home Medical (QIPT) United States $0.125B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.095B 0.00
InterCure (INCR) Israel $0.072B 0.00
Rockwell Medical (RMTI) United States $0.072B 37.00
Jushi Holdings (JUSHF) United States $0.065B 0.00
Ayr Wellness (AYRWF) United States $0.060B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Exagen (XGN) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Safety Shot (SHOT) United States $0.045B 0.00
Allurion Technologies (ALUR) United States $0.027B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Nephros (NEPH) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.84
SNDL (SNDL) Canada $0.000B 0.00